UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 6-K
Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16 under the
Securities Exchange Act of 1934
May 21,
2025
Commission
File Number 001-14978
SMITH & NEPHEW plc
(Registrant’s
name)
Building 5, Croxley Park, Hatters Lane
Watford, England, WD18 8YE
(Address
of principal executive office)
Indicate
by check mark whether the registrant files or will file annual
reports under cover of Form 20-F or Form 40-F.
Form
20-F ✓
Form 40-F
__
SMITH & NEPHEW PLC
21 May 2025
NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS
DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY
ASSOCIATED WITH THEM
This announcement is made in accordance with the UK Market Abuse
Regulation (Regulation (EU) 596/2014, as it forms part of domestic
law by virtue of the European Union (Withdrawal) Act
2018).
1. VESTING OF SHARE AWARDS UNDER THE GLOBAL SHARE PLAN
2020
On 20 May 2025, the Company received notification of the following
transactions in US$0.20 ordinary shares (the "Shares") in Smith
& Nephew plc (the "Company") following the vesting of awards
under the Smith & Nephew Global Share Plan 2020.
All figures in these columns are stated to 6 decimal places where
applicable.
i. VESTING OF PERFORMANCE SHARE PLAN AWARDS MADE
UNDER THE SMITH & NEPHEW GLOBAL SHARE PLAN 2020
The
awards were granted under the Global Share Plan 2020 and vested on
20 May 2025 at 59.35% of target. A number of Shares were sold to
cover taxation obligations arising on the vesting of the awards as
detailed in the table below. The number of Shares acquired includes
the dividend equivalent Shares which the participant received on
the vested Shares. The table below sets out the number of
shares under award which vested. The remaining shares under
award have lapsed.
|
Reason for the notification
|
|
|
Initial
notification /Amendment
|
Initial
notification
|
|
Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
|
|
|
Name
|
Smith
& Nephew plc
|
|
LEI
|
213800ZTMDN8S67S1H61
|
|
Details of the transaction(s): section to be repeated for (i) each
type of instrument; (ii) each type of transaction; (iii) each date;
and (iv) each place where transactions have been
conducted
|
|
|
Description
of the financial instrument, type of instrument
|
Smith
& Nephew plc ordinary shares of USD 0.20 each
|
|
Identification
code
|
ISIN:
GB0009223206
|
|
Nature
of the transaction
|
Vesting
on 20 May 2025 of Performance Share Plan awards granted under the
Smith & Nephew Global Share Plan 2020, and subsequent sale of
shares to cover tax liability
|
|
Date of
Transaction
|
2025 -
05 - 20
|
|
Place
of Transaction
|
London
Stock Exchange (XLON)
|
|
Name
(Position)
|
Status
|
Price (£)
|
Volume
|
Aggregated information
|
|
Deepak
Nath
(Chief
Executive Officer)
|
PDMR
|
10.875359
|
83,938
(of which 34,477 were sold and 49,461 were retained)
|
N/A
Single Transaction
|
ii. VESTING
OF CONDITIONAL AWARDS MADE UNDER THE SMITH & NEPHEW GLOBAL
SHARE PLAN 2020
The awards were granted under the Global Share Plan 2020 and vested
on 20 May 2025. A number of Shares were sold to cover taxation
obligations arising on the vesting of the awards as detailed in the
table below.
The following relates to individuals included in the below
notification:
|
Reason for the notification
|
|
|
Initial
notification /Amendment
|
Initial
notification
|
|
Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
|
|
|
Name
|
Smith
& Nephew plc
|
|
LEI
|
213800ZTMDN8S67S1H61
|
|
Details of the transaction(s): section to be repeated for (i) each
type of instrument; (ii) each type of transaction; (iii) each date;
and (iv) each place where transactions have been
conducted
|
|
|
Description
of the financial instrument, type of instrument
|
Smith
& Nephew plc ordinary shares of USD 0.20 each
|
|
Identification
code
|
ISIN:
GB0009223206
|
|
Nature
of the transaction
|
Vesting
on 20 May 2025 of Conditional Share awards granted under the Smith
& Nephew Global Share Plan 2020, and subsequent sale of shares
to cover tax liability
|
|
Date of
Transaction
|
2025 -
05 - 20
|
|
Place
of Transaction
|
London
Stock Exchange (XLON)
|
|
Name
(Position)
|
Status
|
Price (£)
|
Volume
|
Aggregated information
|
|
Craig
Gaffin
(President,
Global Orthopaedics)
|
PDMR
|
10.875359
|
1,551
(of which 379 were sold and 1,172 were retained)
|
N/A
Single Transaction
|
|
Elga
Lohler
(Chief
HR Officer)
|
PDMR
|
10.875359
|
20,174
(of which 8,026 were sold and 12,148 were retained)
|
N/A
Single Transaction
|
|
Vasant
Padmanabhan
(President
Research & Development and ENT)
|
PDMR
|
10.875359
|
19,626
(of which 8,708 were sold and 10,918 were retained)
|
N/A
Single Transaction
|
|
Rohit
Kashyap
(President,
Advanced Wound Management and Global Commercial
Operations)
|
PDMR
|
10.875359
|
11,949
(of which 2,920 were sold and 9,029 retained)
|
N/A
Single Transaction
|
Philip Horner
Deputy Company Secretary
Smith & Nephew plc
Tel: +44 (0)1923 477100
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf
by the undersigned, thereunto duly authorized.
|
|
|
|
|
|
|
Smith & Nephew plc
|
|
|
|
(Registrant)
|
|
|
|
|
|
|
|
|
|
Date:
May 21, 2025
|
By:
|
/s/
Helen Barraclough
|
|
|
|
Helen
Barraclough
|
|
|
|
Company
Secretary
|